Terms: = Sarcomas AND TIMP1, CLGI, EPA, EPO, HCI, TIMP, TIMP-1 AND Clinical Outcome
2 results:
1. Analysis of HIF-1a and its regulator, PHD2, in retroperitoneal sarcomas: clinico-pathologic implications.
Huang JH; Lee FS; Pasha TL; Sammel MD; Karakousis G; Xu G; Fraker D; Zhang PJ
Cancer Biol Ther; 2010 Feb; 9(4):303-11. PubMed ID: 20026900
[TBL] [Abstract] [Full Text] [Related]
2. Tissue and serum loss of metalloproteinase inhibitors in high grade soft tissue sarcomas.
Benassi MS; Magagnoli G; Ponticelli F; Pazzaglia L; Zanella L; Gamberi G; Ragazzini P; Ferrari C; Mercuri M; Picci P
Histol Histopathol; 2003 Oct; 18(4):1035-40. PubMed ID: 12973672
[TBL] [Abstract] [Full Text] [Related]
